• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

质子泵抑制剂作为艰难梭菌腹泻的一个风险因素。

Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea.

作者信息

Cunningham R, Dale B, Undy B, Gaunt N

机构信息

Plymouth Public Health Laboratory, Derriford Hospital, Plymouth, UK.

出版信息

J Hosp Infect. 2003 Jul;54(3):243-5. doi: 10.1016/s0195-6701(03)00088-4.

DOI:10.1016/s0195-6701(03)00088-4
PMID:12855243
Abstract

Clostridium difficile is the main infectious cause of colitis in hospital inpatients. The incidence is increasing, and it is associated with significant mortality, morbidity, and increased length of stay. The main risk factor is use of broad-spectrum antibiotics, and antibiotic restriction is the most effective control measure. We carried out a retrospective case-control study to investigate whether use of proton pump inhibitors (PPI) was an additional risk factor. PPI use within the preceding eight weeks was associated with an increased risk of C. difficile diarrhoea (odds ratio 2.5, 95% CI 1.5-4.2). Reduction of unnecessary PPI use may be an additional strategy to reduce the incidence of this infection.

摘要

艰难梭菌是医院住院患者结肠炎的主要感染病因。其发病率正在上升,且与显著的死亡率、发病率及住院时间延长相关。主要危险因素是使用广谱抗生素,而限制抗生素使用是最有效的控制措施。我们开展了一项回顾性病例对照研究,以调查使用质子泵抑制剂(PPI)是否为另一危险因素。在之前八周内使用PPI与艰难梭菌腹泻风险增加相关(比值比2.5,95%可信区间1.5 - 4.2)。减少不必要的PPI使用可能是降低这种感染发病率的另一策略。

相似文献

1
Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea.质子泵抑制剂作为艰难梭菌腹泻的一个风险因素。
J Hosp Infect. 2003 Jul;54(3):243-5. doi: 10.1016/s0195-6701(03)00088-4.
2
Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor.接受高风险抗生素治疗的患者中,使用质子泵抑制剂与不使用质子泵抑制剂的艰难梭菌感染发生率。
J Hosp Infect. 2016 Feb;92(2):173-7. doi: 10.1016/j.jhin.2015.10.009. Epub 2015 Nov 2.
3
Proton pump inhibitors and diarrhoea related to Clostridium difficile infection in hospitalised patients: a case-control study.质子泵抑制剂与住院患者艰难梭菌感染相关腹泻:病例对照研究。
Intern Med J. 2012 May;42(5):591-4. doi: 10.1111/j.1445-5994.2012.02770.x.
4
Magnitude and direction of the association between Clostridium difficile infection and proton pump inhibitors in adults and pediatric patients: a systematic review and meta-analysis.艰难梭菌感染与质子泵抑制剂在成人和儿科患者中的关联程度和方向:系统评价和荟萃分析。
J Gastroenterol. 2018 Jan;53(1):84-94. doi: 10.1007/s00535-017-1369-3. Epub 2017 Jul 25.
5
Proton pump inhibitors and risk for Clostridium difficile associated diarrhea.质子泵抑制剂与艰难梭菌相关性腹泻的风险
Biomed J. 2014 Jul-Aug;37(4):178-83. doi: 10.4103/2319-4170.128002.
6
Incidence of Clostridium difficile associated diarrhoea in a tertiary care hospital.一家三级护理医院中艰难梭菌相关性腹泻的发病率。
J Assoc Physicians India. 2012 Nov;60:26-8.
7
Clostridium difficile infection and proton pump inhibitors.艰难梭菌感染与质子泵抑制剂。
Curr Opin Pediatr. 2012 Oct;24(5):627-31. doi: 10.1097/MOP.0b013e328355a3e1.
8
Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection.质子泵抑制剂与医院获得性艰难梭菌感染的风险。
Mayo Clin Proc. 2013 Oct;88(10):1085-90. doi: 10.1016/j.mayocp.2013.07.004. Epub 2013 Sep 5.
9
Continuous Proton Pump Inhibitor Therapy and the Associated Risk of Recurrent Clostridium difficile Infection.连续质子泵抑制剂治疗与复发性艰难梭菌感染的相关风险。
JAMA Intern Med. 2015 May;175(5):784-91. doi: 10.1001/jamainternmed.2015.42.
10
Clostridium difficile associated diarrhoea: An increased problem.艰难梭菌相关性腹泻:一个日益严重的问题。
Med Clin (Barc). 2016 Dec 16;147(12):543-546. doi: 10.1016/j.medcli.2016.09.026. Epub 2016 Nov 4.

引用本文的文献

1
Adverse Risks Associated With Proton Pump Inhibitors: A Systematic Review.质子泵抑制剂相关的不良风险:一项系统评价
Gastroenterol Hepatol (N Y). 2009 Oct;5(10):725-734.
2
Proton pump inhibitor therapy usage and associated hospitalization rates and critical care outcomes of COVID-19 patients.质子泵抑制剂治疗的使用与 COVID-19 患者相关的住院率和重症监护结局。
Sci Rep. 2022 May 9;12(1):7596. doi: 10.1038/s41598-022-11680-0.
3
Proton Pump Inhibitors and Incident Clostridioides difficile Infection: Beyond Controversy, Pragmatic Approaches Are Needed.
质子泵抑制剂与艰难梭菌感染:超越争议,需要务实的方法。
Clin Infect Dis. 2021 Jun 15;72(12):e1090-e1092. doi: 10.1093/cid/ciaa1856.
4
Effects of oral/enteral nutrition alone versus plus pantoprazole on gastrointestinal bleeding in critically ill patients with low risk factor: a multicenter, randomized controlled trial.单独口服/肠内营养与加用泮托拉唑对低危重症患者胃肠道出血的影响:一项多中心、随机对照试验。
Turk J Med Sci. 2020 Jun 23;50(4):776-783. doi: 10.3906/sag-1911-42.
5
From Nursery to Nursing Home: Emerging Concepts in Clostridioides difficile Pathogenesis.从托儿所到疗养院:艰难梭菌发病机制中的新兴概念。
Infect Immun. 2020 Jun 22;88(7). doi: 10.1128/IAI.00934-19.
6
Infection: An Epidemiology Update.感染:流行病学最新进展
Clin Colon Rectal Surg. 2020 Mar;33(2):49-57. doi: 10.1055/s-0040-1701229. Epub 2020 Feb 25.
7
The Phylogeny and Biological Function of Gastric Juice-Microbiological Consequences of Removing Gastric Acid.胃液的微生物组学后果:胃酸去除的系统发育和生物学功能。
Int J Mol Sci. 2019 Nov 29;20(23):6031. doi: 10.3390/ijms20236031.
8
Risk factors for Clostridioides difficile infection and colonization among patients admitted to an intensive care unit in Shanghai, China.中国上海某 ICU 住院患者艰难梭菌感染和定植的危险因素。
BMC Infect Dis. 2019 Nov 11;19(1):961. doi: 10.1186/s12879-019-4603-1.
9
How do potentially inappropriate medications and polypharmacy affect mortality in frail and non-frail cognitively impaired older adults? A cohort study.潜在不适当药物和多种药物治疗如何影响体弱和认知功能正常的老年衰弱患者的死亡率?一项队列研究。
BMJ Open. 2019 May 14;9(5):e026171. doi: 10.1136/bmjopen-2018-026171.
10
2019 update of the WSES guidelines for management of () infection in surgical patients.2019 年 WSES 外科患者()感染管理指南更新。
World J Emerg Surg. 2019 Feb 28;14:8. doi: 10.1186/s13017-019-0228-3. eCollection 2019.